RenovoRx, Inc. (RNXT) KPIs and segments
RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30163% above fair value
$1.16−0.06 (-4.92%)
Close on Nov 12, 2026Market cap $52.35MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive RenovoRx's business
Coming soon
This tab will track the numbers specific to RenovoRx's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?